Details for New Drug Application (NDA): 021009
✉ Email this page to a colleague
The generic ingredient in ALOCRIL is nedocromil sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nedocromil sodium profile page.
Summary for 021009
Tradename: | ALOCRIL |
Applicant: | Allergan |
Ingredient: | nedocromil sodium |
Patents: | 0 |
Pharmacology for NDA: 021009
Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 021009
Suppliers and Packaging for NDA: 021009
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009 | NDA | Allergan, Inc. | 0023-8842 | 0023-8842-05 | 1 BOTTLE, DROPPER in 1 CARTON (0023-8842-05) / 5 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 8, 1999 | TE: | RLD: | Yes |
Expired US Patents for NDA 021009
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription